Brief: Applied Therapeutics Announces FDA Acceptance And Priority Review Of New Drug Application For Govorestat For The Treatment Of Classic Galactosemia

Applied Therapeutics

28/02/2024 13:28

Feb 28 (Reuters) - Applied Therapeutics Inc  APLT.O :
    * APPLIED THERAPEUTICS INC: PDUFA TARGET ACTION DATE OF
AUGUST 28,
2024
    * APPLIED THERAPEUTICS ANNOUNCES FDA ACCEPTANCE AND PRIORITY
REVIEW OF NEW DRUG APPLICATION FOR GOVORESTAT FOR THE TREATMENT
OF CLASSIC GALACTOSEMIA

Source text for Eikon:  ID:nGNX1qSxLP 
Further company coverage:  APLT.O 

 ((Reuters.Briefs@thomsonreuters.com;))